Chlorzoxazone

CAS 95-25-0 8 current records 10 historicalSmall Molecule

Who holds supplier records for Chlorzoxazone? 8 organisations hold a current record for Chlorzoxazone: an active US FDA Type II Drug Master File. A further 10 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), China (1) and Taiwan (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Chlorzoxazone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/chlorzoxazone

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    4 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Chlorzoxazone. Country is the organisation's recorded country, not necessarily the manufacturing site.

India4China1Taiwan1Country not recorded for 2
Need Chlorzoxazone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (10)

Organisations whose Type II DMFs for Chlorzoxazone are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • Seven Star Pharmaceutical Co., Ltd.
    Taiwan · Inactive DMF 20471 · filed Apr 2007
  • United States · Inactive DMF 7291 · filed Jan 1988
  • TOKUYAMA CORP
    Inactive DMF 6563 · filed Aug 1986
  • HELSINN CHEMICALS SA
    Inactive DMF 6518 · filed Apr 1986
  • HOECHST CELANESE CORP
    Inactive DMF 5543 · filed Sept 1984
  • HEXAGON LABORATORIES INC
    Inactive DMF 5339 · filed Feb 1984
  • YODOGAWA PHARMACEUTICAL CO LTD
    Inactive DMF 4995 · filed Apr 1983
  • CILAG CHEMIE AG
    Inactive DMF 4956 · filed Apr 1983
  • DAIWA PHARMACEUTICAL CO LTD
    Inactive DMF 4797 · filed Jan 1983
  • MALLINCKRODT CHEMICAL WORKS
    Inactive DMF 2354 · filed Nov 1974

Overview

Chlorzoxazone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1371).

Chemical identity

IUPAC name
5-chloro-3H-1,3-benzoxazol-2-one
Canonical SMILES
C1=CC2=C(C=C1Cl)NC(=O)O2
InChIKey
TZFWDZFKRBELIQ-UHFFFAOYSA-N
Synonyms
Chlorzoxazone, Clorzoxazona, NSC-26189, Paraflex, Parafon, Parafon-forte, Parafon forte dsc, Strifon, Strifon forte dsc, 5-Chloro-2(3H)-benzoxazolone, 5-Chloro-2-benzoxazolone, 2(3H)-Benzoxazolone, 5-chloro-

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Muscle Relaxant
Physiologic effect
Centrally-mediated Muscle Relaxation

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Chlorzoxazone?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Chlorzoxazone: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CENTAUR PHARMACEUTICALS PVT LTD (India), RAMPEX LABS PRIVATE LTD (India), RINI LIFE SCIENCE PRIVATE LIMITED, SAURAV CHEMICALS LTD, SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (China), STHREE CHEMICALS LLC (India) and SYN-TECH CHEM AND PHARM CO LTD (Taiwan). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Chlorzoxazone Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 32843), CENTAUR PHARMACEUTICALS PVT LTD (DMF 32112), RAMPEX LABS PRIVATE LTD (DMF 35300), RINI LIFE SCIENCE PRIVATE LIMITED (DMF 42784), SAURAV CHEMICALS LTD (DMF 33920), SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (DMF 40870), STHREE CHEMICALS LLC (DMF 30862) and SYN-TECH CHEM AND PHARM CO LTD (DMF 8736). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Chlorzoxazone records mean?

10 organisations have only inactive Type II DMFs for Chlorzoxazone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Chlorzoxazone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Chlorzoxazone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.